Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer.
暂无分享,去创建一个
P. Malmström | A. Sherif | M. de la Torre | M. Torre | M Thörn | A Sherif | M De La Torre | P U Malmström | M. Thörn | Per-Uno Malmström | Magnus Thörn
[1] F. Burkhard,et al. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. , 2002, European urology.
[2] K. Steven,et al. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. , 1998, The Journal of urology.
[3] F. Wawroschek,et al. Radioisotope guided pelvic lymph node dissection for prostate cancer. , 2001, The Journal of urology.
[4] P. Clark. Radical cystectomy for carcinoma of the bladder. , 1978, British journal of urology.
[5] M. Soloway,et al. Cis‐diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer , 1981, Cancer.
[6] L. Mazzucchelli,et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. , 1994, The Journal of urology.
[7] R. Cote,et al. Molecular determinants of outcome in bladder cancer. , 1999, The cancer journal from Scientific American.
[8] R. Babaian,et al. Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer. , 1987, The Journal of urology.
[9] R. Babaian,et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Thörn. Lymphatic mapping and sentinel node biopsy: is the method applicable to patients with colorectal and gastric cancer? , 2000, The European journal of surgery = Acta chirurgica.
[11] D. Krag,et al. Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.
[12] W. See,et al. Staging of advanced bladder cancer. Current concepts and pitfalls. , 1992, The Urologic clinics of North America.
[13] P. Ell,et al. Clinical role of sentinel-lymph-node biopsy in breast cancer. , 2002, The Lancet. Oncology.
[14] M. Resnick,et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.
[15] Donald L. Morton,et al. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.
[16] C. Cordon-Cardo,et al. Genetic and Molecular Markers of Urothelial Premalignancy and Malignancy , 2000, Scandinavian journal of urology and nephrology. Supplementum.
[17] J. Thüroff,et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis , 2000, BJU international.
[18] F. Wawroschek,et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. , 2003, European urology.
[19] P. Bassi,et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. , 1999, The Journal of urology.
[20] S. Groshen,et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. , 1993, The Journal of urology.
[21] J. Portillo,et al. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. , 1995, The Journal of urology.
[22] M. Ross,et al. Recent advances in the care of the patient with malignant melanoma. , 1997, Annals of surgery.
[23] K. Matsumoto,et al. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder. , 2000, International journal of oncology.
[24] R. Wahlqvist,et al. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. , 1996, The Journal of urology.
[25] H. Müller-Gärtner,et al. Staging of Pelvic Lymph Nodes in Neoplasms of the Bladder and Prostate by Positron Emission Tomography with 2-[18F]-2-Deoxy-D-Glucose , 1999, European Urology.
[26] R. Cabanas,et al. An approach for the treatment of penile carcinoma , 1977, Cancer.
[27] D. de Jong,et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. , 2000, The Journal of urology.
[28] M. Gomha,et al. A predictive model of survival after radical cystectomy for carcinoma of the bladder , 2000, BJU international.
[29] S. Groshen,et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. , 1993, The American journal of pathology.
[30] M. Deavers,et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] D. Weaver,et al. Gamma-probe-guided lymph node localization in malignant melanoma. , 1993, Surgical oncology.
[32] A E Giuliano,et al. Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. , 1998, The New England journal of medicine.
[33] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.